Clin2
NCT04892251Possibly a fitRecruiting

Ketamine-assisted therapy for opioid use disorder

Opioid-use Disorder

Part of Mental health clinical trials.

This trial tests whether ketamine-assisted therapy can help people with opioid use disorder, alongside standard treatment with buprenorphine. It also looks at whether you can safely take part in group mindfulness-style sessions during the study.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
60 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have a diagnosis of opioid use disorder
  • You are currently receiving opioid use disorder treatment with buprenorphine
  • You have not previously taken part in a mindfulness-based program
  • You are not pregnant (and not breastfeeding)
  • You have no serious medical or mental conditions that would stop you from joining mindfulness-style group sessions

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07369089Not yet recruiting· Phase 2
Ketamine-assisted therapy for opioid use disorder

This study tests whether ketamine, combined with a type of counseling called MORE, can help people who are struggling with opioid use disorder despite taking buprenorphine. It aims to reduce drug use and improve treatment outcomes.

La Jolla, California
NCT06943859Recruiting· Phase 2
Ketamine for opioid use disorder

This study tests whether ketamine, when added to methadone treatment, helps reduce opioid use and cravings. It is for adults with opioid use disorder who are already in a methadone program and have had recent cravings or illicit use. The trial involves multiple visits and follow-up assessments.

Baltimore, Maryland
NCT06642181Recruiting· Phase 1
Guanfacine and meditation with buprenorphine for opioid use disorder

This study tests if adding a medication called guanfacine and mindfulness meditation to standard buprenorphine treatment helps people with opioid use disorder. It looks at whether this combination can improve treatment outcomes and reduce opioid use.

Newark, New Jersey
NCT06585709Recruiting
Brain stimulation for opioid use disorder treatment

This trial tests if brain stimulation can help people starting buprenorphine for opioid use disorder. It aims to improve treatment outcomes and support recovery.

Durham, North Carolina
NCT07801703Not yet recruiting· Phase 2/Phase 3
Ketamine and therapy for treatment-resistant depression

This study combines behavioral activation therapy (a type of counseling that helps you re-engage in positive activities) with ketamine infusions to treat depression that hasn't improved with standard antidepressants. The goal is to see if adding this therapy makes ketamine work better and last longer.

Ottawa, Ontario
NCT07009158Recruiting· Phase 1/Phase 2
Ketamine plus therapy for pain and PTSD

This trial tests if ketamine combined with talk therapy helps people with both chronic pain and PTSD. Participants receive ketamine through an IV in group therapy sessions over several weeks, with the goal of reducing pain and PTSD symptoms.

Kingston, Ontario

Hear when a new Opioid Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.